Specific Cytotoxicity of TCR Vα23-Vβ13 Gene-Modified T-cells

YIN Qing-song,TAN Huo,YANG Li-jian,CHEN Shao-hua,ZHA Xian-feng,YE Jing-mei,LI Yang-qiu
DOI: https://doi.org/10.3969/j.issn.1000-4718.2011.02-010
2011-01-01
Abstract:AIM: To analyze the cytotoxicity of TCR Vα23-Vβ13 gene-modified T-cells specific to diffuse large B-cell lymphoma(DLBCL) associated antigens in vitro. METHODS: The identified full-length TCR Vβ13 and Vα23 genes of monoclonally expanded T-cells in the peripheral blood from a DLBCL patient were amplified and cloned.The bicistronic recombinant plasmid TCR Vβ13-IRES-TCR Vα23 was constructed and transfected into T-cells isolated from a healthy individual by NucleofectorTM technology.The mRNA expression of antigen-specific TCR Vα23 and Vβ13 genes and the corresponding proteins were determined by real-time PCR and Western blotting,respectively.The specific cytotoxicity of TCR gene-transferred T-cells in vitro was detected. RESULTS: The recombinant plasmid was constructed successfully and verified by restriction enzyme digestion and nucleotide sequencing.The co-expression of antigen-specific TCR Vα23 and Vβ13 genes at mRNA and protein levels in the transfected healthy T-cells were observed in vitro.Three days after transfection,the cytotoxicity of TCR gene-transduced CD3+T-cells against Toledo cells was significantly higher than that against Raji cells or Molt-4 cells.The DLBCL-specific cytotoxic T-lymphocytes(CTL) were inducted. CONCLUSION: The bicistronic eukaryotic expression plasmid TCR Vβ13-IRES-TCR Vα23 specific to DLBCL-associated antigens is constructed successfully.The TCR gene-transferred T-cells display the ability of DLBCL-specific cytotoxicity.
What problem does this paper attempt to address?